Deacetylmoxisylyte
Code | Size | Price |
---|
TAR-T31246-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T31246-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
Deacetylmoxisylyte is a biochemical.
CAS:
35231-36-8
Molecular Weight:
237.34
Purity:
0.98
SMILES:
OC=1C=C(C(OCCN(C)C)=CC1C)C(C)C
References
Marquer C, Bressolle F. High-performance liquid chromatographic determination of the conjugate metabolites of moxisylyte in human plasma and urine. J Chromatogr B Biomed Sci Appl. 1997 Apr 11;691(2):389-96. PubMed PMID: 9174276.
Marquer C, Trouvin JH, Lacolle JY, Dupont C, Jacquot C. Pharmacokinetics of a prodrug thymoxamine: dose-dependence of the metabolite ratio in healthy subjects. Eur J Drug Metab Pharmacokinet. 1991 Jul-Sep;16(3):183-8. PubMed PMID: 1839981.
Marquer C, Bressolle F. Moxisylyte: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in impotence. Fundam Clin Pharmacol. 1998;12(4):377-87. Review. PubMed PMID: 9711459.
Roquebert J, Malek A, Creuzet MH, Cognie F, Pontagnier H. Alpha 1- and alpha 2-adrenoceptor selectivity of moxisylyte (thymoxamine) and its metabolites in the pithed rat. Arch Int Pharmacodyn Ther. 1983 Dec;266(2):282-93. PubMed PMID: 6320755.